Arkolith/Insider Trading/ERAS/Form 4

Wei Lin

Chief Medical OfficerErasca, Inc. (ERAS) · full profile →Form 4 · filed Feb 3, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 1, 2023Other(J)2$3.89$8316K
Feb 1, 2023Other(J)2K$4.10$7K316K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 1, 2023Grant(A)560K—$0560K

Transaction Codes

J
Other acquisition / disposition
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-006480) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML